Clinical Trial: Necrotizing Enterocolitis (Nec) and B. Lactis in Premature Babies
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Prevention of NEC in Preterm Infants With B. Lactis
Brief Summary: The purpose of the trial is to demonstrate the effect of B. lactis in reducing the incidence of Necrotizing Enterocolitis (NEC) compared to placebo in preterm infants.
Detailed Summary:
Sponsor: Nestlé
Current Primary Outcome: NEC onset [ Time Frame: 6 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Antibiotic administration and stool microbiology [ Time Frame: 6 weeks ]
Original Secondary Outcome: Same as current
Information By: Nestlé
Dates:
Date Received: September 15, 2009
Date Started: November 2009
Date Completion:
Last Updated: November 22, 2013
Last Verified: November 2013